Inactive/Delisted stock

HCW Biologics Stock (NASDAQ:HCWB)


Chart

Previous Close

$3.31

52W Range

$2.77 - $100.80

50D Avg

$4.37

200D Avg

$11.30

Market Cap

$8.76M

Avg Vol (3M)

$133.16K

Beta

0.67

Div Yield

-

HCWB Company Profile


HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as pulmonary fibrosis; and HCW9302 for auto-immune diseases, such as alopecia areata and metabolic diseases. It also develops HCW9201, a cell-based therapy that is in Phase II clinical trials for the treatment of patients with relapsed/refractory acute myeloid leukemia; and HCW9206 for the treatment of acute myeloid leukemia. The company was incorporated in 2018 and is headquartered in Miramar, Florida.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

36

IPO Date

Jul 20, 2021

Website

HCWB Performance


Peer Comparison


TickerCompany
EVAXEvaxion Biotech A/S
MNOVMediciNova, Inc.
CSBRChampions Oncology, Inc.
MOLNMolecular Partners AG
TickerGate Footer Logo

Tickergate is an advanced stock research & comparison platform for informed data-driven investment decisions. 100% customizable, institutional-grade data, easy to use.

Company

AboutContact

Connect

LinkedIn

©2025 Tickergate

Tickergate does not provide financial advices and does not issue recommendations or offers to buy stocks of sell any securities. Information is provided 'as-is' and solely for informational purposes as an advice. Tickergate does not bear any responsibility or any losses or damages that may occur as a result of reliance on this data.
Start a conversation

Ask me anything about stocks, markets, or financial data.

Market Trends
Compare Stocks